United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average (own scale)
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for BioCardia, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| ROE | -950.12% | 255.54% | 71.78% | 41.73% | 29.43% | 22.84% |
|---|---|---|---|---|---|---|
| Sector average | 20.42% | 71.17% | 5.82% | 58.79% | 17.46% | 2.74% |
| ROA | -230.57% | -339.5% | -571.23% | -570.21% | -569.92% | -572.72% |
| Total Assets | $3,413.00K | $1,438.76K | $1,438.76K | $1,438.76K | $1,438.76K | $1,438.76K |
| Net Income | -$8,228.00K | -$8,235.82K | -$8,218.65K | -$8,203.99K | -$8,199.71K | -$8,240.12K |